Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Randomized, Observer-blind, Active-controlled Study to Compare Non-inferior Immunogenicity of a DTaPgen Vaccine to a Licensed DTaP-IPV, When Administered to Healthy Toddlers Aged of 15-36 Months Old.

NCT07213089 is registered in ClinicalTrials.gov with BioNet-Asia Co., Ltd. as lead sponsor.

NCT NCT07213089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07213089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Randomized, Observer-blind, Active-controlled Study to Compare Non-inferior Immunogenicity of a DTaPgen Vaccine to a Licensed DTaP-IPV, When Administered to Healthy Toddlers Aged of 15-36 Months Old.
Lead sponsor
BioNet-Asia Co., Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
July 13, 2020
Completion date
May 12, 2022
Enrollment
290 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pertussis whooping cough